Factors affecting treatment adherence among leprosy patients: Perceptions of healthcare providers

被引:1
作者
Pepito, Veincent Christian F. [1 ,2 ]
Loreche, Arianna Maever [1 ,2 ,3 ]
Samontina, Rae Erica D. [1 ,2 ]
Abdon, Sarah Jane A. [1 ,4 ]
Fuentes, David Norman L. [1 ,5 ]
Saniel, Ofelia P. [1 ,6 ]
机构
[1] Univ Philippines Manila, Coll Publ Hlth, Manila, Philippines
[2] Ateneo Manila Univ, Sch Med & Publ Hlth, Pasig, Philippines
[3] Univ Philippines Manila, Natl Inst Hlth, Natl Clin Trials & Translat Ctr, Manila, Philippines
[4] Mandaluyong City Med Ctr, Dept Internal Med, Mandaluyong City, Philippines
[5] St Lukes Med Ctr, Inst Neurosci, Quezon City, Philippines
[6] Symmetrix Res Consultancy Co, Manila, Philippines
关键词
Treatment adherence; Leprosy; Healthcare providers; Primary care; Qualitative study; Philippines; MULTIDRUG THERAPY; KNOWLEDGE; STIGMA; PHILIPPINES; MEDICATION; SERVICES; DISTRICT; ATTITUDE;
D O I
10.1016/j.heliyon.2023.e17975
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Treatment adherence is a vital aspect in the management of chronic diseases like leprosy; however, most studies on treatment adherence focus on patients. This study aims to examine the perceptions of healthcare providers on factors that can promote or prevent patients from adhering to treatment. Methods: We conducted three focus group discussions (FGDs) with healthcare providers who have at least one year experience in managing leprosy in three large leprosy case-holding hospitals in Metro Manila, Philippines. We audio-recorded, transcribed, translated the FGD proceedings, and analyzed the transcripts thematically to identify patient-intrinsic and patient-extrinsic enablers and barriers to treatment adherence of leprosy patients. Results: Patient-intrinsic motivators to complete treatment include innate desire to be cured, fear of infecting family and friends, fear of disability, good knowledge about the disease, need for medical clearance to be considered fit to work, and experiencing leprosy reactions. Patientextrinsic motivators to complete treatment include free treatment, immediate and sufficient counselling, flexibility in treatment, follow-up and motivation of healthcare workers, and presence of Hansen's Club and support groups. Patient-intrinsic barriers to good treatment adherence include distance between residence and hospital, financial and opportunity costs, adverse drug reactions, misconceptions about being cured, disabilities and presence of leprosy reactions, stubbornness and/or laziness, and undergoing clinical depression. Patient-extrinsic barriers to good treatment adherence include poor availability of MDT, transfer to other leprosy treatment facilities without informing current facility, and stigma. Conclusion: Healthcare providers perceive that patient-intrinsic and patient-extrinsic factors influence the treatment adherence of leprosy patients through different mechanisms. We highlight the role of healthcare provider attitudes, stigma, and support groups in promoting treatment adherence.
引用
收藏
页数:8
相关论文
共 51 条
  • [1] Alsolami F., 2012, Clinical Medicine and Diagnostics, V2, P27, DOI [10.5923/j.cmd.20120204.02, DOI 10.5923/J.CMD.20120204.02]
  • [2] Advancing Universal Health Coverage in the Philippines through self-care interventions
    Amit, Arianna Maever L.
    Pepito, Veincent Christian F.
    Dayrit, Manuel M.
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 26
  • [3] [Anonymous], 2013, NVivo 10
  • [4] [Anonymous], 2022, PROMOTING TREATMENT
  • [5] Medication Adherence: Truth and Consequences
    Brown, Marie T.
    Bussell, Jennifer
    Dutta, Suparna
    Davis, Katherine
    Strong, Shelby
    Mathew, Suja
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (04) : 387 - 399
  • [6] Bussell Jennifer K, 2017, Clin Diabetes, V35, P171, DOI 10.2337/cd016-0029
  • [7] Cagayan MSFS., 2020, INT J PUBLIC HLTH SC, V9, P137, DOI DOI 10.11591/IJPHS.V9I2.20381
  • [8] Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15
    Cambau, E.
    Saunderson, P.
    Matsuoka, M.
    Cole, S. T.
    Kai, M.
    Suffys, P.
    Rosa, P. S.
    Williams, D.
    Gupta, U. D.
    Lavania, M.
    Cardona-Castro, N.
    Miyamoto, Y.
    Hagge, D.
    Srikantam, A.
    Hongseng, W.
    Indropo, A.
    Vissa, V.
    Johnson, R. C.
    Cauchoix, B.
    Pannikar, V. K.
    Cooreman, E. A. W. D.
    Pemmaraju, V. R. R.
    Gillini, L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (12) : 1305 - 1310
  • [9] Cervantes F.M., 2022, ANTIDISCRIMINATION B
  • [10] Chaptini C, 2015, LEPROSY REV, V86, P307